Skip Navigation

Prescribing for Diabetes, England - 2005/06 to 2015/16

Publication date: 09:30 August 03, 2016


Prescribing for Diabetes reports on and examines prescribing trends on medicines prescribed in primary care in England for the treatment and monitoring of diabetes during the period April 2005 to March 2016. Diabetes is a high profile clinical area, as the prevalence is increasing and costs associated with treating patients with diabetes are also increasing.

Key Facts

  • Drugs used in diabetes (British National Formulary (BNF) section 6.1) now make up 10.6 per cent of total primary care net ingredient costs (NIC) and 4.6 per cent of prescription items.
  • In the financial year 2015/16 there were 49.7 million items prescribed for diabetes at a total net ingredient cost of £956.7 million. Up from 27.1 million prescription items and £513.9 million in 2005/06.
  • Antidiabetic drugs (BNF section 6.1.2) make up 44.2 per cent of the total £956.7 million net ingredient cost of drugs used in diabetes. 71.3 per cent of prescription items for diabetes.


Date Range: 01 April 2005 to 31 March 2016
Geographical coverage: England
Geographical granularity: Primary Care Trusts, Clinical Commissioning Groups

Have a question? Call us on 0300 303 5678 or contact

Tell us what you think of the new website beta.

We use cookies to provide you with a better service. Carry on browsing if you're happy with this, or find out how to manage cookies. Find out more